[Caprine arthritis-encephalitis: trial of an adjuvant vaccine preparation. I. Clinical and virological study]

Comp Immunol Microbiol Infect Dis. 1993 Apr;16(2):131-6. doi: 10.1016/0147-9571(93)90005-p.
[Article in French]

Abstract

In purpose to protect goats against caprine arthritis encephalitis virus (CAEV), the first group of kids (I) was inoculated with purified, inactivated and adjuvant-treated virions, the second group (II) with adjuvant and the third one (III) with culture medium. 2-4 months later, the three groups were challenged with virulent CAEV by intraarticular route. On the clinical level, vaccinated and challenged kids show more early and severe arthritis than other groups. On the virological level, isolation of lentivirus from white blood cells and different organs is more important in group I than groups II and III. Therefore, vaccinations with inactivated and adjuvant-treated virions do not protect against a virulent challenge; there is an enhancement of lesions. We note that the adjuvant elicits a mild non-specific protection against virulent challenge.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Arthritis-Encephalitis Virus, Caprine / immunology*
  • Arthritis-Encephalitis Virus, Caprine / isolation & purification
  • Culture Media
  • Female
  • Freund's Adjuvant
  • Goat Diseases / immunology
  • Goat Diseases / microbiology*
  • Goat Diseases / prevention & control
  • Goats / immunology
  • Injections, Intra-Articular
  • Lentivirus Infections / immunology
  • Lentivirus Infections / microbiology
  • Lentivirus Infections / prevention & control
  • Lentivirus Infections / veterinary*
  • Leukocytes / microbiology
  • Severity of Illness Index
  • Vaccines, Inactivated
  • Viral Vaccines / immunology*

Substances

  • Culture Media
  • Vaccines, Inactivated
  • Viral Vaccines
  • Freund's Adjuvant